Search

Gerald R. Ewoldt

Examiner (ID: 4358, Phone: (571)272-0843 , Office: P/1644 )

Most Active Art Unit
1644
Art Unit(s)
1644
Total Applications
1060
Issued Applications
256
Pending Applications
142
Abandoned Applications
661

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 1043858 [patent_doc_number] => 06867292 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-03-15 [patent_title] => 'Characterization of novel gene cbl-SL' [patent_app_type] => utility [patent_app_number] => 09/434708 [patent_app_country] => US [patent_app_date] => 1999-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 14 [patent_no_of_words] => 20402 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/867/06867292.pdf [firstpage_image] =>[orig_patent_app_number] => 09434708 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/434708
Characterization of novel gene cbl-SL Nov 4, 1999 Issued
Array ( [id] => 352368 [patent_doc_number] => 07491388 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2009-02-17 [patent_title] => 'Uses of fibroblasts or supernatants from fibroblasts for the suppression of immune responses in transplantation' [patent_app_type] => utility [patent_app_number] => 09/807810 [patent_app_country] => US [patent_app_date] => 1999-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 4248 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/491/07491388.pdf [firstpage_image] =>[orig_patent_app_number] => 09807810 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/807810
Uses of fibroblasts or supernatants from fibroblasts for the suppression of immune responses in transplantation Nov 3, 1999 Issued
Array ( [id] => 1338203 [patent_doc_number] => 06585973 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-01 [patent_title] => 'Method for preparing solid phase conjugated vaccine' [patent_app_type] => B1 [patent_app_number] => 09/428498 [patent_app_country] => US [patent_app_date] => 1999-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10203 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/585/06585973.pdf [firstpage_image] =>[orig_patent_app_number] => 09428498 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/428498
Method for preparing solid phase conjugated vaccine Oct 27, 1999 Issued
Array ( [id] => 749276 [patent_doc_number] => 07022483 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-04-04 [patent_title] => 'Methods for identifying and isolating antigen-specific T cells' [patent_app_type] => utility [patent_app_number] => 09/421506 [patent_app_country] => US [patent_app_date] => 1999-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 58 [patent_no_of_words] => 37164 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 196 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/022/07022483.pdf [firstpage_image] =>[orig_patent_app_number] => 09421506 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/421506
Methods for identifying and isolating antigen-specific T cells Oct 18, 1999 Issued
Array ( [id] => 1408167 [patent_doc_number] => 06528307 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-04 [patent_title] => 'Cytolytic T-cell clones against colorectal carcinoma' [patent_app_type] => B1 [patent_app_number] => 09/403310 [patent_app_country] => US [patent_app_date] => 1999-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 18 [patent_no_of_words] => 11341 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/528/06528307.pdf [firstpage_image] =>[orig_patent_app_number] => 09403310 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/403310
Cytolytic T-cell clones against colorectal carcinoma Oct 17, 1999 Issued
Array ( [id] => 4181903 [patent_doc_number] => 06159723 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-12 [patent_title] => 'Renin-active substance' [patent_app_type] => 1 [patent_app_number] => 9/417305 [patent_app_country] => US [patent_app_date] => 1999-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5160 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/159/06159723.pdf [firstpage_image] =>[orig_patent_app_number] => 417305 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/417305
Renin-active substance Oct 12, 1999 Issued
Array ( [id] => 1238568 [patent_doc_number] => 06685936 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-02-03 [patent_title] => 'Suppressor cells induced by culture with mesenchymal stem cells for treatment of immune responses in transplantation' [patent_app_type] => B2 [patent_app_number] => 09/415627 [patent_app_country] => US [patent_app_date] => 1999-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 4483 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/685/06685936.pdf [firstpage_image] =>[orig_patent_app_number] => 09415627 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/415627
Suppressor cells induced by culture with mesenchymal stem cells for treatment of immune responses in transplantation Oct 11, 1999 Issued
09/415854 ISOAGGLUTININ-DEPLETED BLOOD COMPOSITIONS AND METHODS OF MAKING SAME Oct 7, 1999 Abandoned
Array ( [id] => 1564282 [patent_doc_number] => 06338836 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-15 [patent_title] => 'Asthma analysis method employing hyperpolarized gas and magnetic resonance imaging' [patent_app_type] => B1 [patent_app_number] => 09/406372 [patent_app_country] => US [patent_app_date] => 1999-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2223 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 217 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/338/06338836.pdf [firstpage_image] =>[orig_patent_app_number] => 09406372 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/406372
Asthma analysis method employing hyperpolarized gas and magnetic resonance imaging Sep 27, 1999 Issued
09/269922 USE OF AN IMMUNOGLOBULIN PREPARATION FOR PRODUCING AN ORAL MEDICAMENT PREVENTING HEMOLYTIC UREMIC SYNDROME AND PREPARATION FOR THE SAME Sep 26, 1999 Abandoned
Array ( [id] => 7390065 [patent_doc_number] => 20040037839 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-26 [patent_title] => 'T-CELL RECEPTOR BETA-LIKE PROTEIN' [patent_app_type] => new [patent_app_number] => 09/405940 [patent_app_country] => US [patent_app_date] => 1999-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 19019 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20040037839.pdf [firstpage_image] =>[orig_patent_app_number] => 09405940 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/405940
T-CELL RECEPTOR BETA-LIKE PROTEIN Sep 26, 1999 Abandoned
Array ( [id] => 1030977 [patent_doc_number] => 06878528 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-04-12 [patent_title] => 'Polynucleotides encoding a mammalian Langerhans cell antigen' [patent_app_type] => utility [patent_app_number] => 09/787192 [patent_app_country] => US [patent_app_date] => 1999-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23245 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/878/06878528.pdf [firstpage_image] =>[orig_patent_app_number] => 09787192 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/787192
Polynucleotides encoding a mammalian Langerhans cell antigen Sep 22, 1999 Issued
Array ( [id] => 7219477 [patent_doc_number] => 20040072153 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'PASTEURELLA NEURAMINIDASE CODING SEQUENCES, COMPOSITIONS AND DIAGNOSTIC METHODS' [patent_app_type] => new [patent_app_number] => 09/400122 [patent_app_country] => US [patent_app_date] => 1999-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11935 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20040072153.pdf [firstpage_image] =>[orig_patent_app_number] => 09400122 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/400122
Pasteurella neuraminidase diagnostic methods and immunoassay kit Sep 20, 1999 Issued
Array ( [id] => 4404302 [patent_doc_number] => 06228363 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-08 [patent_title] => 'Peptides for the treatment of systemic lupus erythematosus' [patent_app_type] => 1 [patent_app_number] => 9/399494 [patent_app_country] => US [patent_app_date] => 1999-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 4417 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/228/06228363.pdf [firstpage_image] =>[orig_patent_app_number] => 399494 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/399494
Peptides for the treatment of systemic lupus erythematosus Sep 19, 1999 Issued
Array ( [id] => 1506010 [patent_doc_number] => 06440426 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-27 [patent_title] => 'Antigen-containing formulation and methods of use thereof' [patent_app_type] => B1 [patent_app_number] => 09/399217 [patent_app_country] => US [patent_app_date] => 1999-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6468 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/440/06440426.pdf [firstpage_image] =>[orig_patent_app_number] => 09399217 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/399217
Antigen-containing formulation and methods of use thereof Sep 16, 1999 Issued
Array ( [id] => 4233409 [patent_doc_number] => 06165735 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-26 [patent_title] => 'Parasitic helminth asparaginase proteins, nucleic acid molecules, and uses thereof' [patent_app_type] => 1 [patent_app_number] => 9/397979 [patent_app_country] => US [patent_app_date] => 1999-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29054 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/165/06165735.pdf [firstpage_image] =>[orig_patent_app_number] => 397979 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/397979
Parasitic helminth asparaginase proteins, nucleic acid molecules, and uses thereof Sep 15, 1999 Issued
09/393652 METHODS AND COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF GRAFT REJECTION USING HEAT SHOCK PROTEINS Sep 9, 1999 Abandoned
Array ( [id] => 322297 [patent_doc_number] => 07517527 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-14 [patent_title] => 'Immunotoxin with in vivo T cell suppressant activity and methods of use' [patent_app_type] => utility [patent_app_number] => 09/389565 [patent_app_country] => US [patent_app_date] => 1999-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 22 [patent_no_of_words] => 19563 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/517/07517527.pdf [firstpage_image] =>[orig_patent_app_number] => 09389565 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/389565
Immunotoxin with in vivo T cell suppressant activity and methods of use Sep 2, 1999 Issued
Array ( [id] => 6174501 [patent_doc_number] => 20020155118 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-24 [patent_title] => 'ALKALOID GLYCOSIDE FOR USE AS A MEDICAMENT' [patent_app_type] => new [patent_app_number] => 09/242442 [patent_app_country] => US [patent_app_date] => 1999-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4287 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20020155118.pdf [firstpage_image] =>[orig_patent_app_number] => 09242442 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/242442
Alkaloid glycoside for use as a medicament Aug 26, 1999 Issued
09/383372 USE OF ENDOTHELIN INHIBITORS FOR TREATMENT OR PREVENTION FIBROTIC DISORDERS Aug 25, 1999 Abandoned
Menu